Evidence map›Paper›PMID 20126442›Full record

ArticlePLoS pathogens2010

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Joseph K Wong, Matthew C Strain, Rodin Porrata, Elizabeth Reay, Sumathi Sankaran-Walters, Caroline C Ignacio, Theresa Russell, Satish K Pillai, David J Looney, Satya Dandekar

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 138 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Modelling HIV-1 control and remission.NPJ systems biology and applications · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. CD8Nature communications · 2023
    Article
  13. CD8Immunity · 2023
    Article
  14. CD8Nature microbiology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. The CD8Microbiology and molecular biology reviews : MMBR · 2021
    Review
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Joseph K WongDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Matthew C Strain
Rodin Porrata
Elizabeth Reay
Sumathi Sankaran-Walters
Caroline C Ignacio
Theresa Russell
Satish K Pillai
David J Looney
Satya Dandekar
University of California, San Diego · USUniversity of California, Davis · USVA San Diego Healthcare System · USUniversity of California, Berkeley · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SONIA JAIN · 1994 to 2026
$78.4M
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIESR24RR016001 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REIMANN, KEITH A. · 2000 to 2011
$8.1M
HIGH RESOLUTION STRUCTURAL STUDY OF DSDNA BACTERIOPHAGER01AI040101 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI JOHNSON, JOHN EMIL · 1996 to 2014
$5.2M
HIV reservoir and CD4 repopulation in gut lymphoid tissueR01DK061297 · NIDDK · UNIVERSITY OF CALIFORNIA DAVIS · PI DANDEKAR, SATYA · 2002 to 2012
$3.5M
PATHOGENESIS OF INTESTINAL DYSFUNCTION IN SIMIAN AIDSR01DK043183 · NIDDK · UNIVERSITY OF CALIFORNIA DAVIS · PI DANDEKAR, SATYA · 1992 to 2010
$2.9M
Antiviral Role of APOBEC3 in HIV/HCV Coinfected PatientsK01DA024654 · NIDA · VITALANT · PI PILLAI, SATISH KUMAR · 2008 to 2012
$902k
NCRR NIH HHS R24 RR016001NCRR NIH HHS RR016001NIAID NIH HHS AI040101NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI040101NIDA NIH HHS K01 DA024654NIDDK NIH HHS DK043183NIDDK NIH HHS DK061297NIDDK NIH HHS R01 DK043183NIDDK NIH HHS R01 DK061297NINDS NIH HHS NS051145
6 · The paper itself

Abstract

The CD8+ T-cell is a key mediator of antiviral immunity, potentially contributing to control of pathogenic lentiviral infection through both innate and adaptive mechanisms. We studied viral dynamics during antiretroviral treatment of simian immunodeficiency virus (SIV) infected rhesus macaques following CD8+ T-cell depletion to test the importance of adaptive cytotoxic effects in clearance of cells productively infected with SIV. As previously described, plasma viral load (VL) increased following CD8+ T-cell depletion and was proportional to the magnitude of CD8+ T-cell depletion in the GALT, confirming a direct relationship between CD8+ T-cell loss and viral replication. Surprisingly, first phase plasma virus decay following administration of antiretroviral drugs was not slower in CD8+ T-cell depleted animals compared with controls indicating that the short lifespan of the average productively infected cell is not a reflection of cytotoxic T-lymphocyte (CTL) killing. Our findings support a dominant role for non-cytotoxic effects of CD8+ T-cells on control of pathogenic lentiviral infection and suggest that cytotoxic effects, if present, are limited to early, pre-productive stages of the viral life cycle. These observations have important implications for future strategies to augment immune control of HIV.

Indexed as

AnimalsAnti-Retroviral AgentsCD8-Positive T-LymphocytesGene ExpressionGene Products, gagGene Products, nefMacaca mulattaModels, TheoreticalSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-Lymphocytes, CytotoxicViral LoadViremiaAnti-Retroviral AgentsGene Products, gagGene Products, nef

Identifiers

PMID20126442
PMCPMC2813272
OpenAlexW2039521754

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.